Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

W Boucher

Showing results (111-120 of 177) with videos related to

Pageof 18
Sort By:
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|January 4, 2008
The epidemic of antibiotic-resistant infections: a call to action for the medical community from the Infectious Diseases Society of AmericaBrad Spellberg, Robert Guidos, David Gilbert, et al.
British Journal of Pharmacology|September 23, 2008
Luteolin inhibits myelin basic protein-induced human mast cell activation and mast cell-dependent stimulation of Jurkat T cellsD Kempuraj, M Tagen, B P Iliopoulou, et al.
BMC Structural Biology|October 6, 2006
The crystal structure of superoxide dismutase from Plasmodium falciparumIan W Boucher, Andrzej M Brzozowski, James A Brannigan, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|September 12, 2018
Considerations for Clinical Trials of Staphylococcus aureus Bloodstream Infection in AdultsThomas L Holland, Henry F Chambers, Helen W Boucher, et al.
Immunology Letters|August 28, 2003
IL-10 subfamily members: IL-19, IL-20, IL-22, IL-24 and IL-26P Conti, D Kempuraj, S Frydas, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|June 27, 2009
Antimicrobial agents for complicated skin and skin-structure infections: justification of noninferiority margins in the absence of placebo-controlled trialsBrad Spellberg, George H Talbot, Helen W Boucher, et al.
International Journal of Immunopathology and Pharmacology|June 12, 2003
Interleukin-19 (IL-19) network revisitedD Kempuraj, S Frydas, K Kandere, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|March 28, 2023
Applying Desirability of Outcome Ranking End PointsMichael W Dunne, Steven I Aronin, Anita F Das, et al.
Immunology|November 1, 1995
Monocyte chemotactic protein-1 provokes mast cell aggregation and [3H]5HT releaseP Conti, W Boucher, R Letourneau, et al.
Transplantation Proceedings|December 1, 1977
HLA-D typing with an association of Dw2 and absent immune responses towards herpes simplex (type i) antigen in multiple sclerosisD W Paty, H K Cousin, C R Stiller, et al.
Pageof 18

Showing results (111-120 of 177) with videos related to

Sort By:
Pageof 18
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|January 4, 2008
The epidemic of antibiotic-resistant infections: a call to action for the medical community from the Infectious Diseases Society of AmericaBrad Spellberg, Robert Guidos, David Gilbert, et al.
British Journal of Pharmacology|September 23, 2008
Luteolin inhibits myelin basic protein-induced human mast cell activation and mast cell-dependent stimulation of Jurkat T cellsD Kempuraj, M Tagen, B P Iliopoulou, et al.
BMC Structural Biology|October 6, 2006
The crystal structure of superoxide dismutase from Plasmodium falciparumIan W Boucher, Andrzej M Brzozowski, James A Brannigan, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|September 12, 2018
Considerations for Clinical Trials of Staphylococcus aureus Bloodstream Infection in AdultsThomas L Holland, Henry F Chambers, Helen W Boucher, et al.
Immunology Letters|August 28, 2003
IL-10 subfamily members: IL-19, IL-20, IL-22, IL-24 and IL-26P Conti, D Kempuraj, S Frydas, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|June 27, 2009
Antimicrobial agents for complicated skin and skin-structure infections: justification of noninferiority margins in the absence of placebo-controlled trialsBrad Spellberg, George H Talbot, Helen W Boucher, et al.
International Journal of Immunopathology and Pharmacology|June 12, 2003
Interleukin-19 (IL-19) network revisitedD Kempuraj, S Frydas, K Kandere, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|March 28, 2023
Applying Desirability of Outcome Ranking End PointsMichael W Dunne, Steven I Aronin, Anita F Das, et al.
Immunology|November 1, 1995
Monocyte chemotactic protein-1 provokes mast cell aggregation and [3H]5HT releaseP Conti, W Boucher, R Letourneau, et al.
Transplantation Proceedings|December 1, 1977
HLA-D typing with an association of Dw2 and absent immune responses towards herpes simplex (type i) antigen in multiple sclerosisD W Paty, H K Cousin, C R Stiller, et al.
Pageof 18